Effect of the Human Immunodeficiency Virus Type 1 Reverse Transcriptase Polymorphism Leu-214 on Replication Capacity and Drug Susceptibility

被引：12
|
作者：
Carmen Puertas, Maria [1 ]
Jose Buzon, Maria [1 ]
Artese, Anna [2 ]
Alcaro, Stefano [2 ]
Menendez-Arias, Luis [3 ,4 ]
Perno, Carlo Federico [5 ]
Clotet, Bonaventura [1 ]
Ceccherini-Silberstein, Francesca [5 ]
Martinez-Picado, Javier [1 ,6 ]
机构：
[1] IrsiCaixa Fdn, Hosp Germans Trias & Pujol, Badalona 08916, Spain
[2] Univ Catanzaro Magna Graecia, Dept Pharmacobiol Sci, Catanzaro, Italy
[3] CSIC, Ctr Biol Mol Severo Ochoa, Madrid, Spain
[4] Univ Autonoma Madrid, Madrid, Spain
[5] Univ Roma Tor Vergata, Dept Expt Med, Rome, Italy
[6] Inst Catalana Recerca & Estudis Avancats, Barcelona, Spain
来源：
JOURNAL OF VIROLOGY | 2009年 / 83卷 / 15期
关键词：
RESISTANCE MUTATIONS; ANTIRETROVIRAL THERAPY; ZIDOVUDINE RESISTANCE; VIROLOGICAL RESPONSE; EXPERIENCED PATIENTS; COMBINATION THERAPY; IN-VITRO; HIV-1; PATTERNS; INHIBITORS;
D O I：
10.1128/JVI.00487-09
中图分类号：
Q93 [微生物学];
学科分类号：
071005 ; 100705 ;
摘要：
A negative association between polymorphism Leu-214 and type-1 thymidine analogue mutations (TAM1) and a positive association with a clinically favorable virological response to thymidine analogue-based combination antiretroviral therapy have been described. In this study, the impact of Leu-214 on replication capacity and resistance to zidovudine (ZDV) of viruses containing TAM1 or TAM2 was determined. Leu-214 decreased the growth rate of viruses bearing Tyr-215, as well as their resistance to ZDV. This observation was confirmed by structural and molecular modeling data, suggesting a regulatory role for Leu-214 in the emergence and phenotypic resistance of TAM1.
引用
收藏
页码：7434 / 7439
页数：6
相关论文
共 50 条
  • [31] Modulation of human immunodeficiency virus type 1 synergistic inhibition by reverse transcriptase mutations
    Basavapathruni, Aravind
    Vingerhoets, Johan
    de Bethune, Marie-Pierre
    Chung, Raymond
    Bailey, Christopher M.
    Kim, Jiae
    Anderson, Karen S.
    BIOCHEMISTRY, 2006, 45 (23) : 7334 - 7340
  • [32] Properties of human immunodeficiency virus type 1 reverse transcriptase recombination upon infection
    Sakuragi, Sayuri
    Shioda, Tatsuo
    Sakuragi, Jun-ichi
    JOURNAL OF GENERAL VIROLOGY, 2015, 96 : 3382 - 3388
  • [33] Biochemical mechanism of human immunodeficiency virus type 1 reverse transcriptase resistance to stavudine
    Lennerstrand, J
    Stammers, DK
    Larder, BA
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2001, 45 (07) : 2144 - 2146
  • [34] Induction of apoptosis by a nonnucleoside human immunodeficiency virus type 1 reverse transcriptase inhibitor
    Pilon, AA
    Lum, JJ
    Sanchez-Dardon, J
    Phenix, BN
    Douglas, R
    Badley, AD
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2002, 46 (08) : 2687 - 2691
  • [35] Characterization of the reverse transcriptase of a human immunodeficiency virus type 1 group O isolate
    QuinonesMateu, ME
    Soriano, V
    Domingo, E
    MenendezArias, L
    VIROLOGY, 1997, 236 (02) : 364 - 373
  • [36] Inhibition of human immunodeficiency virus type 1 reverse transcriptase by degradation products of ceftazidime
    Baertschi, SW
    Cantrell, AS
    Kuhfeld, MT
    Lorenz, LJ
    Boyd, DB
    Jaskunas, SR
    ANTIVIRAL CHEMISTRY & CHEMOTHERAPY, 1997, 8 (04): : 353 - 362
  • [37] Metabolism of the human immunodeficiency virus type 1 reverse transcriptase inhibitor delavirdine in rats
    Chang, M
    Sood, VK
    Wilson, GJ
    Kloosterman, DA
    Sanders, PE
    Hauer, MJ
    Fagerness, PE
    DRUG METABOLISM AND DISPOSITION, 1997, 25 (02) : 228 - 242
  • [38] Eukaryotic expression of enzymatically active human immunodeficiency virus type 1 reverse transcriptase
    Isaguliants, MG
    Pokrovskaya, K
    Kashuba, VI
    Pokholok, D
    Hinkula, J
    Wahren, B
    Kochetkov, SN
    FEBS LETTERS, 1999, 447 (2-3) : 232 - 236
  • [39] Different properties of wild type and drug-resistant mutants of human immunodeficiency virus type 1 reverse transcriptase in vitro
    Ijichi, K
    Fujiwara, M
    Shigeta, S
    Konno, K
    Yokota, T
    Baba, M
    MICROBIOLOGY AND IMMUNOLOGY, 1996, 40 (05) : 353 - 358
  • [40] Evaluation of reverse transcriptase and protease inhibitors in two-drug combinations against human immunodeficiency virus replication
    Deminie, CA
    Bechtold, CM
    Stock, D
    Alam, M
    Djang, F
    Balch, AH
    Chou, TC
    Prichard, M
    Colonno, RJ
    Lin, PF
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1996, 40 (06) : 1346 - 1351
12345